1312609-70-3

Upstream product

• 1359869-37-6 C₁₅H₁₄BrN 
• 1359869-36-5 C₉H₁₀IN 
• 32202-61-2 4-aminoindan 
• 1359869-38-7 C₁₅H₁₂Br₂ 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 28179-01-3 1-(7-hydroxyindan-4-yl)ethanone 
• 38998-02-6 1-(7-methoxyindan-4-yl)ethanone 
• 21573-42-2 4-methoxy-2,3-dihydro-1H-indene 
• 40731-98-4 4-hydroxy-2,3-dihydroindan-1-one 
• 1641-41-4 4-indanol 
• 1312609-69-0 (7-acetylindan-4-yl) trifluoromethanesulfonate 
• 149104-90-5 4-acetylphenylboronic acid 

Downstream Products

• 1312609-71-4 C₁₉H₁₆Br₂O₂ 
• 1312608-52-8 C₄₃H₅₄N₄O₁₂ 

Relevant academic research and scientific papers

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment o

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.